ヴィーラナラヤナンスリワニ

ヴィーラナラヤナンスリワニ | Veeranarayanan Srivani

所属機関・部署：
職名：特命助教
ホームページURL (2件)： https://www.jichi.ac.jp/medicine/department/bacteriology/ , https://www.jichi.ac.jp/bacteriology/en/member.html#vani

研究分野 (3件)：応用微生物学 , 生体材料学 , ナノバイオサイエンス

研究キーワード (1件)： Gene Delivery/Editing, CRISPR-Cas, Phage Therapy, Phage Vaccines, Drug Delivery, Biofilms, Theransotics

競争的資金等の研究課題 (2件)：

2021 - 2026 Creation of a technological base for new antibacterial capsids for drug discovery of bacterial infections
2022 - 2022 Development of innovative anti-tuberculosis phage preparations that mimic the latent infection mechanism of tuberculosis bacteria

論文 (37件)：

Feng-Yu Li, Xin-Ee Tan, Yuzuki Shimamori, Kotaro Kiga, Srivani Veeranarayanan, Shinya Watanabe, Yutaro Nishikawa, Yoshifumi Aiba, Yusuke Sato'o, Kazuhiko Miyanaga, et al. Phagemid-based capsid system for CRISPR-Cas13a antimicrobials targeting methicillin-resistant Staphylococcus aureus. Communications biology. 2024. 7. 1. 1129-1129
Longzhu Cui, Shinya Watanabe, Kazuhiko Miyanaga, Kotaro Kiga, Teppei Sasahara, Yoshifumi Aiba, Xin-Ee Tan, Srivani Veeranarayanan, Kanate Thitiananpakorn, Huong Minh Nguyen, et al. A Comprehensive Review on Phage Therapy and Phage-Based Drug Development. Antibiotics. 2024. 13. 9. 870-870
Yuzuki Shimamori, Xin-Ee Tan, Feng-Yu Li, Yutaro Nishikawa, Shinya Watanabe, Teppei Sasahara, Kazuhiko Miyanaga, Yoshifumi Aiba, Srivani Veeranarayanan, Kanate Thitiananpakorn, et al. Efficient synthesis of CRISPR-Cas13a-antimicrobial capsids against MRSA facilitated by silent mutation incorporation. Scientific reports. 2024. 14. 1. 16225-16225
Shinya Watanabe, Chijioke A. Nsofor, Kanate Thitiananpakorn, Xin-Ee Tan, Yoshifumi Aiba, Remi Takenouchi, Kotaro Kiga, Teppei Sasahara, Kazuhiko Miyanaga, Srivani Veeranarayanan, et al. Metabolic remodeling by RNA polymerase gene mutations is associated with reduced β-lactam susceptibility in oxacillin-susceptible MRSA. mBio. 2024. e00339-24
Longzhu Cui, Srivani Veeranarayanan, Kanate Thitiananpakorn, Dhammika Leshan Wannigama. Bacteriophage Bioengineering: A Transformative Approach for Targeted Drug Discovery and Beyond. Pathogens. 2023. 12. 9. 1179-1179

MISC (6件)：

Supplementary Cover Image. ACS Applied Bio Materials. 2019. 2
Front Cover. Nanoscale. 2016. 8
Back Cover. Journal of Materials Chemistry B. 2015. 3
Inside Front Cover. Nanoscale. 2015. 7
Back Cover. Macromolecular Bioscience. 2014. 14

特許 (2件)：

Composition for Nano-Drug Delivery
RGD and transferrin nanoparticle composition

書籍 (1件)：

Book chapter - Nanoparticluate materials for bioimaging. Book: Nanomaterials and hazard assessment. Edited by: P.V. Mohanan.
Educational Book Centre, Mumbai, India 2011

講演・口頭発表等 (22件)：

Nano-Bioimaging: Recent Outcomes.
(Bio Japan 2019)
Precision Nanotheranostics
(Nano Korea 2019)
Cancer nanotechnology in precision medicine: new opportunities in theranostics.
(CSIG 2019)
Lipid-Polymer Hybrid Vescicles for Brain Cancer Theranostics,
(Liposome Research Days (LRD), Hokkaido, Japan. 2019)
Fingerprinting In Vivo Protein Corona-Carbon Nanohorn Interaction.
(Sixth Symposium On Carbon Nanomaterials Biology, Medicine & Toxicology 2015)

学歴 (3件)：

2009 - 2012 東洋大学学際・融合科学研究科
2005 - 2007 University of Madras Biomedical Genetics M.Sc
2002 - 2005 University of Madras Plant Biology & Biotechnology B.Sc

経歴 (5件)：

2024/06 - 現在自治医科大学医学部感染・免疫学講座細菌学部門特命助教
2022/06 - 2024/06 自治医科大学医学部
2020/10 - 2022/06 自治医科大学
2012/04 - 2020/09 東洋大学
2009/04 - 2012/03 東洋大学学際・融合科学研究科

受賞 (8件)：

2019 - Elsevier Cell Symposia Travel Award
2013 - IUPAC IUPAC Young Researcher Award
2012 - Nanocon 2012 Dr. Tasilo Prnka Prize
2009 - MEXT Monbukagakusho Scholarship
2007 - University of Madras Rank 2, M.Sc

全件表示

所属学会 (4件)：

Japanese Society of Bacteriology , Certified Publons Academy Peer Reviewer - Publons , Kolabtree - Freelance Scientific Consultant , The Society of Nano Science and Technology

※　J-GLOBALの研究者情報は、researchmapの登録情報に基づき表示しています。登録・更新については、こちらをご覧ください。

前のページに戻る

ヴィーラナラヤナン スリワニ

ヴィーラナラヤナンスリワニ